Abstract#
The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.
To cite this publication, please use the following BibTeX entry:
@article{svanbergEarlyStimulatedImmune2022,
abstract = {The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.},
author = {Svanberg, Rebecka and MacPherson, Cameron and Zucco, Adrian and Agius, Rudi and Faitova, Tereza and Andersen, Michael Asger and da Cunha-Bang, Caspar and Gjærde, Lars Klingen and Møller, Maria Elizabeth Engel and Brooks, Patrick Terrence and Lindegaard, Birgitte and Sejdic, Adin and Gang, Anne Ortved and Hersby, Ditte Stampe and Brieghel, Christian and Nielsen, Susanne Dam and Podlekareva, Daria and Hald, Annemette and Bay, Jakob Thaning and Marquart, Hanne and Lundgren, Jens and Lebech, Anne-Mette and Helleberg, Marie and Niemann, Carsten Utoft and Ostrowski, Sisse Rye},
copyright = {2022 The Author(s)},
doi = {10.1038/s43856-022-00178-5},
issn = {2730-664X},
journal = {Communications Medicine},
keywords = {Innate immunity,Viral infection},
langid = {english},
month = {September},
number = {1},
pages = {1--15},
publisher = {Nature Publishing Group},
title = {Early Stimulated Immune Responses Predict Clinical Disease Severity in Hospitalized COVID-19 Patients},
urldate = {2022-09-19},
volume = {2},
year = {2022}
}